Literature DB >> 11907350

Update in medical therapy of ulcerative colitis: a practical approach.

Seymour Katz1.   

Abstract

The bewildering array of medications in the therapy of inflammatory bowel disease (IBD) often confounds the clinician in the choice of specific agents regarding the balance between safety and efficacy. This review surveys and evaluates currently available IBD therapies as well as those used in clinical trials of ulcerative colitis. The primary purpose is to provide the busy clinician with a practical guide to the use of established and newly emerging medical therapies of IBD.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11907350     DOI： 10.1097/00004836-200204000-00004

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


  4 in total

Review 1.  Drug therapy for ulcerative colitis.

Authors:  Chang-Tai Xu; Shu-Yong Meng; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

Review 3.  Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis.

Authors:  Richard B R Muijsers; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Pouchitis in Children: Therapeutic Options.

Authors:  Jean Perrault
Journal:  Curr Treat Options Gastroenterol       Date:  2002-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.